81 matches for your search in the start-up spotlight
rssACARYON is your partner for the identification, development and optimization of probiotic strains, prebiotic approaches and microbiome applications.
ACARYON is your partner for the identification, development and optimization of probiotic strains, prebiotic approaches and microbiome applications.
Enduro Genetics is a deeptech company transforming biomanufacturing by solving the challenge of microbial productivity. Its patented synthetic addiction technology, Enduro Sense, boosts yields, reduces costs and waste, and enables scalable, sustainable production across biochemicals, alternative ...
Noema Pharma is a clinical-stage biotech company advancing a portfolio of transformative therapeutics utilizing first-in-disease approaches targeting neuroscience-based conditions with high unmet need. Noema has four programs currently in active Phase 2 clinical trials evaluating pain in ...
AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases. Our differentiation lies in our unique quantum and statistical mechanics algorithms fueling a ...
Founded in 2019 by Dr. Fabiana Fantinel and Dr. Alessandro Carfagnini, CO2BioClean is an innovative start-up based in Eschborn, Germany, developing a fermentation process that converts carbon dioxide into biodegradable polymers. At CO2BioClean, we believe that we can play our part in helping ...
Founded in 2019 by Dr. Fabiana Fantinel and Dr. Alessandro Carfagnini, CO2BioClean is an innovative start-up based in Eschborn, Germany, developing a fermentation process that converts carbon dioxide into biodegradable polymers. At CO2BioClean, we believe that we can play our part in helping ...
Vicebio is focused on developing next-generation respiratory virus vaccines using the Molecular Clamp Technology. The company was founded with investment from Medicxi and acquired the rights to the Molecular Clamp technology through a license from UniQuest, the commercialization arm of The ...
Myricx Bio (“Myricx”) is a UK biotech company focused on the discovery and development of a completely novel class of payloads for antibody-drug conjugates (ADCs), based on inhibitors of N-Myristoyltransferases (NMT) for the treatment of cancer. NMT is an enzyme that adds a specific lipid ...
HAYA Therapeutics is a precision medicines company developing programmable therapeutics targeting regulatory RNAs derived from the dark genome, a cell information processing unit, to reprogram pathological cell states for a broad range of diseases, including cardiovascular disease and cancer. The ...